Browse the evidence

Tirzepatide is a novel treatment option for Type 2 diabetes mellitus (T2DM) that may benefit individuals with cardiovascular disease or heart failure.

Tirzepatide may be considered for T2DM patients with cardiovascular concerns.

Physical activity contributes principally to the maintenance of weight loss rather than the induction of weight loss.

Emphasize physical activity for maintaining weight loss in treatment plans.

The study suggests that patient-delivered interventions may be effective in community and clinical settings for weight loss maintenance.

Consider exploring patient-delivered interventions in various settings for effective weight maintenance.

Coconut milk supplementation induced beneficial changes in the lipid profile, decreasing LDL and non-HDL levels while increasing HDL levels.

Incorporating coconut milk into the diet may improve lipid profiles, particularly for individuals with elevated LDL levels.

The subgroup with elevated baseline LDL levels benefited most from coconut milk supplementation.

Individuals with high LDL levels may see greater improvements in their lipid profiles by consuming coconut milk.

The MC4R rs17782313 polymorphism has positive effects on dietary glycemic index (GI) and glycemic load (GL) (B = 1.577; P ≤ 0.01 for GI; B = 1.235; P ≤ 0.01 for GL).

Understanding the genetic basis of GI and GL can inform dietary recommendations for obesity management.

Both IF and KD enhance insulin sensitivity, promote autophagy, reduce inflammation, and activate energy-regulating pathways (AMPK) while inhibiting mTOR.

Understanding these mechanisms can help practitioners explain the benefits of IF and KD to patients.

There was a significant main effect for time on raw RIRDIFF, indicating a slight decrease in raw RIRDIFF over time.

Trainers may observe that RIR predictions become slightly more accurate over time with consistent training.

There was a greater tendency to underestimate RIR in later sessions and during higher repetition sets.

Coaches should be aware that athletes may underestimate their RIR as training progresses.

Some studies showed a possible positive effect of phosphatidic acid on body composition and performance improvements.

While there may be some positive effects noted, the lack of consistent evidence suggests caution in recommending PA.

Male individuals lost a significantly larger proportion of weight as lean soft tissue (LST) compared to female individuals, with means of 0.33 kg and 0.25 kg respectively.

Practitioners should consider gender differences in body composition changes during weight loss interventions.

Bone mineral content (BMC) increased during the weight loss period, leading to a smaller reduction in fat-free mass (FFM) compared to LST.

Practitioners should note the increase in BMC during weight loss, which may influence overall body composition assessments.

The composition of weight loss tracked as predicted a priori from weight change and baseline body composition.

Practitioners can use baseline body composition to predict changes during weight loss interventions.

Quality of life outcomes generally showed improvements with incretin-based therapies (IBTs).

Clinicians can expect improvements in quality of life for patients using IBTs.

USB were a better replacement than ASB for altering taste preference.

Practitioners should consider promoting USB over ASB for better adherence to low-sugar diets.

Higher ultraprocessed grain intake is associated with increased risk of developing inflammatory bowel disease (IBD), with participants consuming ≥19 g/d having a hazard ratio (HR) of 1.86 compared to those consuming <9 g/d.

Practitioners should advise minimizing ultraprocessed grain consumption to reduce IBD risk.

Fresh bread and rice consumption are associated with lower IBD risk.

Encouraging the consumption of fresh bread and rice may be beneficial for gut health.

Participants with greater ultraprocessed food intake (≥5 servings per day) are linked to a higher risk of developing IBD, with a hazard ratio of 3.95 compared to those consuming <1 serving per day.

Reducing ultraprocessed food intake may lower the risk of IBD.

Understanding patient concerns about the risks of obesity treatment is essential to addressing obesity treatment inertia.

Addressing these concerns may help improve treatment adherence and outcomes.

Baseline body fat percentage was significantly associated with weight gains (r = 0.57) and fat mass gains (r = 0.59) during an 8-week high-fat overfeeding intervention.

Practitioners should consider baseline body fat percentage when assessing weight gain responses to overfeeding.

Body fat percentage was inversely associated with the energy cost of weight (r = -0.38) and fat mass (r = -0.40) gains.

Higher body fat percentage may indicate lower energy efficiency in gaining weight.

Semaglutide improved glycemic control, with HbA1c decreasing by 0.4 ± 0.6%.

Semaglutide may be a beneficial treatment for improving glycemic control in patients with type 1 diabetes.

1 kg/m² lower BMI via the GIP/GIPR score is associated with 29% lower risk of major adverse cardiovascular events (MACE).

Targeting GIP receptor pathways may significantly reduce cardiovascular event risk.

1 kg/m² lower BMI via the GIP/GIPR score is associated with 43% lower risk of heart failure.

Targeting GIP receptor pathways may significantly reduce heart failure risk.